{"id":12113,"date":"2018-12-03T09:55:54","date_gmt":"2018-12-03T14:55:54","guid":{"rendered":"https:\/\/medicarereport.org\/?p=12113"},"modified":"2018-12-03T09:55:54","modified_gmt":"2018-12-03T14:55:54","slug":"government-investigation-finds-flaws-in-the-fdas-orphan-drug-program","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=12113","title":{"rendered":"Government Investigation Finds Flaws In the FDA\u2019s Orphan Drug Program"},"content":{"rendered":"

(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News)<\/p>\n

The Food and Drug Administration has failed to ensure that drugs given prized rare-disease status meet the intent of a 35-year-old law, federal officials revealed in a report Friday.<\/p>\n

The Government Accountability Office, which spent more than a year investigating the FDA\u2019s orphan drug program, said \u201cchallenges continue\u201d in the program that was created to spur development of drugs for diseases afflicting fewer than 200,000 patients. Continue reading article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n

\"\"<\/a><\/p>\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News) The Food and Drug Administration has failed to ensure<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,15],"tags":[],"class_list":["post-12113","post","type-post","status-publish","format-standard","hentry","category-fda","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/12113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12113"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/12113\/revisions"}],"predecessor-version":[{"id":12114,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/12113\/revisions\/12114"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}